uniQure N.V. Gains 51.72%

Wed, Jul 10, 2024 at 07:12 PM

uniQure N.V. (QURE:NASDAQ) rocketted at $10.12, representing a gain of 51.7%. On Wed, Jul 10, 2024, QURE:NASDAQ touched a New 2-Week High of $10.12. The stock got featured on our News Catalysts scanner on Wed, Jul 10, 2024 at 11:33 AM in the 'BIOTECH' category. From Wed, Jun 26, 2024, the stock recorded 33.33% Up Days and 30.00% Green Days

About uniQure N.V. (QURE:NASDAQ)

uniQure NV is engaged in the field of gene therapy platform across three therapeutic focus areas: Liver/Metabolic Disease, Central Nervous System (CNS) Disease and Cardiovascular Disease.

Top 10 Gainers:

Kazia Therapeutics Limited (KZIA:NASDAQ), 248.02%
Inspire Veterinary Partners Inc. (IVP:NASDAQ), 110.23%
Cingulate Inc. (CING:NASDAQ), 74.05%
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 73.18%
Ampco-Pittsburgh Corporation (AP:NYSE), 60.81%
Longeveron Inc. (LGVN:NASDAQ), 58.54%
uniQure N.V. (QURE:NASDAQ), 51.72%
Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 50.83%
Phoenix New Media Limited (FENG:NYSE), 49.26%
Virpax Pharmaceuticals Inc. (VRPX:NASDAQ), 46.55%